Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05239364Not ApplicableRecruiting

Ablation of Consecutive Atrial Tachycardia

Role: lead

NCT05557526Not ApplicableRecruiting

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

Role: lead

NCT07239804Active Not Recruiting

Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments

Role: lead

All 3 trials loaded